EU lists rare nerve disorder as possible side-effect of AstraZeneca COVID-19 vaccine

Europe's medicines regulator has added a rare nerve-damaging disorder, Guillain-Barré syndrome, as a possible side-effect of AstraZeneca's COVID-19 vaccine, regular safety updates from the watchdog showed on Wednesday.

The European Medicines Agency also tagged some other less severe side-effects to vaccines from Johnson & Johnson, Moderna as well as AstraZeneca's shot.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)